These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3838981)

  • 1. HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ; Wright JM
    J Antimicrob Chemother; 1985 Mar; 15(3):305-10. PubMed ID: 3838981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC; Chin NX; Jules K; Labthavikul P
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
    Kessler RE; Bies M; Buck RE; Chisholm DR; Pursiano TA; Tsai YH; Misiek M; Price KE; Leitner F
    Antimicrob Agents Chemother; 1985 Feb; 27(2):207-16. PubMed ID: 3885849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of the cephamycin cefotetan: an in-vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():67-72. PubMed ID: 6404881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.
    Tsuji A; Maniatis A; Bertram MA; Young LS
    Antimicrob Agents Chemother; 1985 Apr; 27(4):515-9. PubMed ID: 3839120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates.
    Giamarellou H; Sahin A; Chryssouli Z
    Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
    King A; Boothman C; Phillips I
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):677-85. PubMed ID: 2226498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of ceftazidime compared with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():57-62. PubMed ID: 19810169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of BMY 28142, a new aminothiazolyl cephalosporin.
    Steele JC; Edwards BH; Rissing JP
    J Antimicrob Chemother; 1985 Oct; 16(4):463-8. PubMed ID: 3840799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.
    Vuye A; Pijck J
    Antimicrob Agents Chemother; 1985 Apr; 27(4):574-7. PubMed ID: 3859244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
    Clarke AM; Zemcov SJ; Campbell ME
    J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
    Visser MR; Hoepelman IM; Beumer H; Rozenberg-Arska M; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest.
    Sader HS; Mimiça I; Rossi F; Zoccoli C; Montelli AC; Sampaio JL; Segura AJ; Magalhães M; Nowakonski A; Mendes CM
    Diagn Microbiol Infect Dis; 1997 Jun; 28(2):87-92. PubMed ID: 9239500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
    Tumah H
    Chemotherapy; 2005 May; 51(2-3):80-5. PubMed ID: 15870501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of meropenem against clinical isolates obtained in Canada.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.